Poseida Therapeutics Stock (NASDAQ: PSTX) stock price, news, charts, stock research, profile.
Open | $3.61 |
Close | $3.37 |
Volume / Avg. | 954.34K / 449.77K |
Day Range | $3.31 - $3.61 |
52 Wk Range | 1.83 - 4.27 |
Market Cap | $330.26M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 5.56% |
Days to Cover | 12.45 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Poseida Therapeutics (NASDAQ:PSTX) through any online brokerage.
Other companies in Poseida Therapeutics’s space includes: Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY), Zentalis Pharma (NASDAQ:ZNTL), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
Poseida Therapeutics has a consensus price target of $16.60.
The stock price for Poseida Therapeutics (NASDAQ: PSTX) is $3.4 last updated September 20, 2024 at 5:54 PM EDT.
There are no upcoming dividends for Poseida Therapeutics.
Poseida Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Poseida Therapeutics.
Poseida Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.